Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscleGLP-1 receptor agonists help lower blood sugar and aid weight loss by reducing fat mass more than muscle mass.
Women advised to pair effective contraception with skinny jabs'Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.
I've been practicing medicine at a renowned institution for 40 years. Society isn't ready for us to reverse the aging process across an entire populationThe surge in GLP-1 receptor agonists signals a transformative moment in weight loss treatments, with potential links to future advancements in aging research.
Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like OzempicEli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.Lilly's shares surged 15% following promising clinical trial results for orforglipron.
The Health Risks and Benefits of Weight-Loss DrugsGLP-1 receptor agonists not only aid in weight loss but also influence various health conditions positively and negatively.
Obesity drugs: huge study highlights new health risksGLP-1 receptor agonists have significant benefits for weight loss and other conditions but also present risks like arthritis and pancreatitis.
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscleGLP-1 receptor agonists help lower blood sugar and aid weight loss by reducing fat mass more than muscle mass.
Women advised to pair effective contraception with skinny jabs'Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity.
I've been practicing medicine at a renowned institution for 40 years. Society isn't ready for us to reverse the aging process across an entire populationThe surge in GLP-1 receptor agonists signals a transformative moment in weight loss treatments, with potential links to future advancements in aging research.
Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like OzempicEli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.Lilly's shares surged 15% following promising clinical trial results for orforglipron.
The Health Risks and Benefits of Weight-Loss DrugsGLP-1 receptor agonists not only aid in weight loss but also influence various health conditions positively and negatively.
Obesity drugs: huge study highlights new health risksGLP-1 receptor agonists have significant benefits for weight loss and other conditions but also present risks like arthritis and pancreatitis.
The Psychology of Addiction and Obesity: New TreatmentsAddiction and obesity share neurological pathways, reinforcing compulsive behaviors.GLP-1 receptor agonists may help regulate both appetite and addictive cravings.Emerging compounds, such as MEAI, are being studied for its potential in addiction treatment.A holistic approach combining therapy, medication, and new research offers hope.
Could obesity drugs help with alcohol cravings? New study suggests potentialGLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.
Opinion | Why We May Soon Use Ozempic to Treat AddictionGLP-1 receptor agonists may help treat addiction-related issues such as obesity and substance use disorders, demonstrating positive effects on cravings and overdose risks.
Diabetes drugs test a new side effect: slowing down symptoms of Parkinson'sGLP-1 receptor agonists have potential benefits beyond just treating diabetes and obesity, potentially impacting diseases like Alzheimer's and Parkinson's positively.
NK2R control of energy expenditure and feeding to treat metabolic diseases - NatureGLP-1 receptor agonists offer effective treatment for obesity and T2D, but their impact is reduced in individuals with both conditions.
Could obesity drugs help with alcohol cravings? New study suggests potentialGLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.
Opinion | Why We May Soon Use Ozempic to Treat AddictionGLP-1 receptor agonists may help treat addiction-related issues such as obesity and substance use disorders, demonstrating positive effects on cravings and overdose risks.
Diabetes drugs test a new side effect: slowing down symptoms of Parkinson'sGLP-1 receptor agonists have potential benefits beyond just treating diabetes and obesity, potentially impacting diseases like Alzheimer's and Parkinson's positively.
NK2R control of energy expenditure and feeding to treat metabolic diseases - NatureGLP-1 receptor agonists offer effective treatment for obesity and T2D, but their impact is reduced in individuals with both conditions.
Enormous potential': weight-loss drugs cut cancer risk by a fifth, research showsWeight-loss drugs can reduce the risk of developing certain types of cancers and improve long-term survival rates.
Obesity surgery in the time of Ozempic: They are not two competing treatments, but rather complementary ones'Innovative anti-obesity drugs are transforming obesity treatment and affecting the role of bariatric surgery.
Enormous potential': weight-loss drugs cut cancer risk by a fifth, research showsWeight-loss drugs can reduce the risk of developing certain types of cancers and improve long-term survival rates.
Obesity surgery in the time of Ozempic: They are not two competing treatments, but rather complementary ones'Innovative anti-obesity drugs are transforming obesity treatment and affecting the role of bariatric surgery.
Weight-loss drugs can improve kidney health, study findsGLP-1 receptor agonists significantly lower the risk of kidney failure, worsening kidney function, and death due to kidney disease by approximately 19%.
Opinion | Inflammation May Be the Root of Our MaladiesThe emerging understanding of GLP-1 receptor agonists indicates their benefits extend beyond weight loss and diabetes to include reducing inflammation and improving overall health.